Congresswoman Julia Letlow US Inactive
Office of Congresswoman Julia Letlow
Congresswoman Julia Letlow
Ad copy
The Biden administration’s border policies have allowed illegal drugs such as fentanyl pour into our country, which risk American lives. Our border patrol agents are completely overwhelmed and desperately in need of more resources. My colleagues and I have brought numerous bills to further secure the border and provide Border Patrol the tools they need. Until President Biden uses the powers that he currently possess to secure our borders, he is putting every American citizen in harm's way. Follow my page to stay connected with my work in Washington.
↗ View in Meta Ad Library (the live creative — image/video/layout)
Performance proxies
| Overall score | 46.2/100 |
| Spend / Reach / Long. / Eff. | 34.7 · 78.0 · 5.2 · 66.9 |
| Spend range | USD 1,000–1,499 |
| Impressions | 100,000 – 124,999 |
| CPM (≈ $/1k impr) | USD 11.11 |
| Est. audience size | 100,001 – 500,000 |
| Days live | 20 (2024-03-01 → 2024-03-21) |
| Created | 2024-03-01 |
| Creative variants | 1 body · 1 headline |
| Platforms | |
| Languages | en |
| Candidate | LA — Julia Letlow |
| Surfaced by | “senate:Julia Letlow” |
🧠 AI analysis
| Issue | immigration |
| Framing | issue advocacy |
| Message type | awareness |
| Emotional appeal | fear |
| Production tier | professional |
| Who pictured | diverse crowd |
| Symbols | border |
| Call to action | learn more |
| Standout element | Large crowd of migrants lined up at a border fence as backdrop to bold red-white-blue headline |
| Tactic | Fear-based issue advocacy tactic tying fentanyl crisis to Biden border policy to drive page follows and build a constituent engagement list. |
Where it ran (delivery by region)
| Louisiana | 99.9% |
| Mississippi | 0.0% |
| Texas | 0.0% |
| Alabama | 0.0% |
| Florida | 0.0% |
| Arkansas | 0.0% |
| Tennessee | 0.0% |
Who saw it (delivery)
| 18-24 · unknown | 0.0% |
| 35-44 · male | 3.0% |
| 18-24 · female | 0.3% |
| 45-54 · unknown | 0.1% |
| 18-24 · male | 0.3% |
| 65+ · female | 25.9% |
| 65+ · male | 10.0% |
| 45-54 · female | 13.0% |
| 55-64 · female | 21.5% |
| 65+ · unknown | 0.2% |
| 35-44 · female | 6.3% |
| 25-34 · male | 1.3% |
| 45-54 · male | 6.6% |
| 55-64 · male | 9.4% |
| 25-34 · female | 1.7% |
| 55-64 · unknown | 0.2% |
| 35-44 · unknown | 0.1% |
| 25-34 · unknown | 0.0% |
